A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
Status:
TERMINATED
Trial end date:
2025-07-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[177Lu\]Lu-EVS459 and the safety and imaging properties of \[68Ga\]Ga-EVS459 in patients aged ≥ 18 years with advanced high-grade serous ovarian cancer (OC) or locally advanced unresectable or metastatic non-squamous non-small cell lung carcinoma (non-sq. NSCLC).